Jun 17, 2026 | Uncategorized
Harm Reduct J. 2026 Jun 17. doi: 10.1186/s12954-026-01486-y. Online ahead of print.ABSTRACTBACKGROUND: As xylazine-adulterated opioids become more prevalent in the U.S., people who use drugs (PWUD) face growing risks from sedation, withdrawal, and wounds. This study...
Jun 16, 2026 | Uncategorized
J Am Pharm Assoc (2003). 2026 Jun 17:103469. doi: 10.1016/j.japh.2026.103469. Online ahead of print.ABSTRACTBACKGROUND: Patients with opioid use disorder encounter challenges obtaining buprenorphine (BUP) at pharmacies, increasing their risk of treatment non-adherence...
Jun 1, 2026 | Uncategorized
Kidney360. 2026 Jun 2. doi: 10.34067/KID.0000001198. Online ahead of print.ABSTRACTBACKGROUND: Legalization of cannabis across several US states may increase its use by individuals on hemodialysis, particularly among those with chronic pain. Contemporary data on...
May 21, 2026 | Uncategorized
Hepatol Commun. 2026 May 22;10(6):e0955. doi: 10.1097/HC9.0000000000000955. eCollection 2026 Jun 1.ABSTRACTBACKGROUND: Chronic pain is common and uniquely challenging to manage in people with cirrhosis. The purpose of this pilot study was to evaluate the feasibility...
May 6, 2026 | Uncategorized
JAMA Netw Open. 2026 May 1;9(5):e2611514. doi: 10.1001/jamanetworkopen.2026.11514.ABSTRACTIMPORTANCE: Due to the impact of high-potency synthetic opioids on medication for opioid use disorder (MOUD) initiation, hospital-based addiction clinicians adapted their...
May 3, 2026 | Uncategorized
J Palliat Med. 2026 May 4:10966218261447000. doi: 10.1177/10966218261447000. Online ahead of print.ABSTRACTEating disorders (ED), particularly anorexia nervosa (AN), represent high-morbidity, high-mortality psychiatric illnesses with multisystem medical complications,...
